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Background and purpose   High-volume infiltration analgesia 
may be effective in postoperative pain management after hip 
arthroplasty but methodological problems prevent exact inter-
pretation of previous studies.
Methods   In a randomized, double-blind placebo-controlled 
trial in 12 patients undergoing bilateral total hip arthroplasty 
(THA) in a fast-track setting, saline or high-volume (170 mL) 
ropivacaine (0.2%) with epinephrine (1:100,000) was adminis-
tered to the wound intraoperatively along with supplementary 
postoperative injections via an intraarticular epidural catheter. 
Oral analgesia was instituted preoperatively with a multimodal 
regimen (gabapentin, celecoxib, and acetaminophen). Pain was 
assessed repeatedly for 48 hours postoperatively, at rest and with 
45° hip flexion.
Results   Pain scores were low and similar between ropivacaine 
and saline administration. Median hospital stay was 4 (range 2–7) 
days.
Interpretation   Intraoperative high-volume infiltration with 
0.2% ropivacaine with repeated intraarticular injections postop-
eratively may not give a clinically relevant analgesic effect in THA 
when combined with a multimodal oral analgesic regimen with 
gabapentin, celecoxib, and acetaminophen.

Continuous epidural analgesia (Choi et al. 2003) or continu-
ous or single-shot peripheral nerve blocks (Boezaart 2006, 
Ilfeld et al. 2008) may provide sufficient analgesia after total 
hip arthroplasty (THA), but both techniques are associated 
with potential motor blockade, thereby hindering early reha-
bilitation (Choi et al 2003, Boezaart 2006, Ilfeld et al. 2008).
Local infiltration analgesia (LIA) (Röstlund and Kehlet 
2007, Kerr and Kohan 2008, Otte et al. 2008) with intraop-
erative infiltration of local anesthetic in the surgical wound 
and subsequent supplementary postoperative intraarticular 
or wound injections has been reported to be effective in knee 
arthroplasty (Andersen et al. 2008). However, for THA only 
limited and inconclusive data are available from placebo-con-
trolled and randomized trials (Bianconi et al. 2003, Andersen 
et al. 2007 a, b, Busch et al. 2010) and from non-randomized 
cohort studies (Kerr and Kohan 2008, Otte et al. 2008). We 
therefore decided to evaluate the analgesic efficacy of LIA in a 
placebo-controlled, randomized and double-blind trial in fast-
track bilateral hip arthroplasty with administration of either 
ropivacaine or saline to the wound, thereby limiting the large 
inter-individual pain response to THA. This design has proven 
valid in assessing the analgesic value of LIA in TKA (Ander-
sen et al. 2008). The primary endpoint was pain on flexion of 
the hip joint 8 hours postoperatively. 
Patients and methods
The study was approved by the local ethics committee (Copen-
hagen and Frederiksberg, Denmark, Reg.no.KF 01 2006-
4062) and the Danish Data Protection Agency (Copenhagen, 
Denmark) and was registered with ClinicalTrials.gov under 
the US National Library of Medicine (Code NCT 00864409). 
The study was performed in compliance with the Helsinki 
Declaration.
12 consecutive patients scheduled for total bilateral hip 
arthroplasty (THA) were included from October 2006 through 
April 2009. The patient characteristics were: 7 men/5 women, 
mean age 60 (range 41–82) years, mean weight 78 (63–106) 
kg, mean BMI 26 (23–31), American Society of Anesthesiolo-
gists physical status I/II = 7/5. All patients received intraop-
erative periarticular infiltration with 170 mL 0.2% ropivacaine 
and epinephrine (1:100,000) in one hip (Otte et al. 2008), and 
similar infiltration with 170 mL 0.9% saline in the opposite 
hip. Patients who were scheduled for bilateral THA and who 
were able to understand and speak Danish and able to give 
informed oral and written consent were included in the study. 424  Acta Orthopaedica 2011; 82 (4): 423–426
Exclusion criteria were treatment with opioids or steroids, 
rheumatoid arthritis or other immunological diseases, history 
of stroke or any neurological or psychiatric disease potentially 
influencing pain perception (e.g. depression, diabetic neurop-
athy etc.), allergies to any of the drugs administered, and BMI 
> 40. All inclusions and data registrations were done by one 
of two investigators, anesthetic procedures were performed 
by one of two anesthesiologists, and all patients were oper-
ated by one of two surgeons. A computer-generated random 
sequence concealed in opaque sealed envelopes, which were 
consecutively opened on the morning of surgery, determined 
which side would receive active treatment. The medicine used 
for each individual patient was prepared by an investigator not 
otherwise involved in patient data collection.
Procedures
Surgery was performed under spinal anesthesia with 15 mg 
plain bupivacaine (3 mL, 5 mg/mL) and propofol was admin-
istered (0.5–5 mg/kg/h) for sedation if required. Low-molec-
ular-weight heparin (4,500 U) was administered subcutane-
ously 6–8 hours postoperatively for thromboprophylaxis and 
once daily until discharge. A standardized intraoperative regi-
men for fluid administration was used with 0.9% saline (5 mL/
kg/h) and colloid (Voluven; 7.5 ml/kg/h) (Holte et al. 2007). 
Bilateral THA was performed sequentially through similar 
standard posterior approaches without the use of minimally 
invasive surgical techniques. Drains were not used. 
In one hip, the patients received infiltration with 340 mg 
ropivacaine (0.2%) with adrenaline (1:100.000) in a total 
volume of 170 mL. The mixture was injected using a system-
atic technique to ensure uniform delivery of the local anes-
thetic to all the tissue that was incised or instrumented during 
the procedure (Otte et al. 2008). The first 50 mL was injected 
in the periacetabular tissues after reaming of the acetabulum 
and before insertion of the acetabular component. After inser-
tion of the femoral component, another 50 mL was evenly 
injected into the cut rotators and the gluteus muscles and the 
lateral part of the femoral muscle where the guide-pin had 
been placed. An epidural catheter (18G) with 3 holes was 
inserted 10 cm distal to the incision and tunneled into the hip 
joint with placement of the tip near the femoral head, after 
which the capsule was closed and 20 mL was injected into the 
catheter to ensure that there was no kinking. Finally, 50 mL 
was injected fanwise into the subcutaneous layers. To mini-
mize the risk of cutaneous blister formation, the subcutane-
ous injections did not contain epinephrine. The opposite hip 
received identical infiltrations with 170 mL 0.9% saline and 
similar placement of a catheter. 
Postoperatively, the patients were transferred to the post-
anesthesia care unit (PACU) and then to a specialized knee 
and hip arthroplasty unit with a well-defined multimodal fast-
track rehabilitation regimen (Husted et al. 2008). 
All patients received orally administered celecoxib (200 
mg every 12 hours; 400 mg preoperatively), slow-release 
paracetamol (2 g every 12 hours), gabapentin (600 mg at 0800 
h and 300 mg at 1600 h daily, initiated preoperatively along 
with patient-controlled analgesia (PCA) for 48 h with intra-
venous morphine (20 µg/kg), lock-out set to 10 min. Apart 
from administration of additional sufentanil or morphine in 
the PACU, the morphine PCA was the only opioid adminis-
tered in the 48-h study period.
8 hours postoperatively, a 20-mL injection of the drug mix-
ture (40 mg ropivacaine and epinephrine (1:100.000)) or 0.9% 
saline was administered intraarticularly through the catheters 
in accordance with randomization. 24 h postoperatively, 50 
mL of the drug mixture (100 mg ropivacaine with epinephrine 
(1:100.000)) or 50 mL 0.9% saline was injected. 
Data collection
The primary endpoint was postoperative pain in each hip 8 
h postoperatively, which was assessed using a visual analog 
scale (VAS) from 0 to 10 cm, with 0 indicating no pain and 10 
indicating the worst possible pain, at rest and upon 45° flex-
ion of the hip with the leg straight. Pain assessment was per-
formed by one of two investigators who were blinded regard-
ing the randomization. 
Pain was recorded at 4, 8, 9, 24, 24.5, 25, 26, 32, and 48 h 
after surgery. Throughout the 48-h study period, the amount of 
morphine delivered via the PCA pump was registered. Length 
of hospital stay (LOS) was also registered. All the patients 
were discharged directly to their homes according to func-
tional discharge criteria: ability to get in and out of bed, to get 
dressed, and to get into and up from a chair; ability to walk 
independently for 50 m with appropriate walking aids; and 
acceptance of discharge.
Statistics
The number of participants was set to 12, since no meaning-
ful power calculation could be performed from published data 
in unilateral hip arthroplasty. Tests for significant differences 
between treatment groups were done using the Wilcoxon 
signed ranks test. All p-values < 0.05 were considered statisti-
cally significant. All data analysis was done using SPSS for 
Windows version 12.0.
Results
VAS pain scores were similar for the hip infiltrated with ropi-
vacaine and epinephrine and the hip infiltrated with saline (p > 
0.05), both at rest and with hip flexion, except for significantly 
less pain at rest 32 h postoperatively in the hip infiltrated with 
saline (p = 0.03) (Figure).
In the PACU, intravenous administration of sufentanil was 
median 10 (interquartile range 0–30) µg, and median cumu-
lative postoperative PCA morphine administration was 6.5 
(4–12) mg, 14 (11–26) mg, 32 (17–53) mg, 36 (19–61) mg, 
and 43 (20–70) mg at 4, 8, 24, 32, and 48 h postoperatively. Acta Orthopaedica 2011; 82 (4): 423–426  425
Mean duration of surgery was 178 (range 76–325) min. 
Median hospital stay was 4 days (range 2–7).
No clinical side effects, including cardiac and hemody-
namic changes requiring intervention, were observed during 
the study period (intraoperatively and 0–48 h postoperatively).
Discussion
We found that there was acceptable pain relief with multi-
modal oral analgesia without any clinically relevant analgesic 
effect of intraoperative high-volume administration of local 
anesthetic and adrenaline with supplementary postoperative 
injections to the wound. In spite of the fact that there have 
been relatively few positive trials published so far (Reilly et 
al. 2005, Busch et al. 2006, Vendittoli et al. 2006, Andersen et 
al. 2007a, b, 2008, Toftdahl et al. 2007) high-volume infiltra-
tion analgesia is increasingly used in major joint replacement 
surgery. Although postoperative administration of local anes-
thetic to the wound may be effective in many surgical pro-
cedures (Liu et al. 2006), our results emphasize the need for 
procedure-specific placebo-controlled trials.
The choice of postoperative analgesic technique after THA 
may include continuous or single-dose peripheral nerve blocks 
or continuous epidural analgesia (Fischer et al 2005, Ilfeld 
et al. 2008), high-volume local infiltration analgesia (LIA) 
(Andersen et al. 2007a, b), continuous local administration of 
anesthetic to the wound (Bianconi et al. 2003), or a multimodal 
analgesic regimen with COX-2 inhibitor or conventional 
NSAID, paracetamol, and gabapentin (Tiipana et al. 2007), 
with weak or strong opioids as rescue analgesics. The choice 
between these analgesic techniques depends on efficacy, side 
effects, costs, and demand for expertise. Our study has shown 
that there is acceptable postoperative pain relief with a multi-
modal parenteral regimen with COX-2 inhibitor, gabapentin, 
have assessed the value of the high-volume infiltration tech-
nique compared to placebo (Andersen et al. 2007b) or epidu-
ral analgesia (Andersen et al. 2007a), and found reduced pain 
and opioid requirements along with improvement in physical 
function 1 week after surgery, these trials did not incorporate 
the multimodal analgesic regimen used in this trial, although 
an NSAID was part of the high-volume infiltration mixture. 
Furthermore, interpretation of some of these trials is hindered 
by the fact that NSAID was only given in the LIA group but 
not in the control group (Andersen et al. 2007a,b, Busch et al. 
2010), since NSAID per se is effective in THA (Fischer et al. 
2005). Due to the design of our study, morphine requirements 
could not be assessed but the overall PCA morphine consump-
tion was minimal (about 40 mg during the first 48 h) despite 
having bilateral THA. Although the high-volume infiltration 
analgesia technique apparently does not provide additional 
analgesia when combined with an effective multimodal anal-
gesic regimen in total hip arthroplasty, further studies evaluat-
ing the LIA technique with other oral analgesic regimes may 
be of interest. Furthermore, the optimal site for administration 
of local anesthetic has not been determined, although continu-
ous infusion of ropivacaine to the subcutaneous layer of the 
wound after THA has been reported to have an analgesic and 
opioid-sparing effect (Bianconi et al. 2003).
Although acceptable postoperative pain relief may be 
achieved with a simple oral analgesic regimen, future improve-
ments in early and late postoperative recovery and rehabilita-
tion should be studied regarding the effect of reduction in the 
neuroendocrine and inflammatory response in THA, where an 
elevated C-reactive protein may be a predictor of convales-
cence after discharge from hospital (Hall et al. 2001). Further 
improvement in postoperative analgesia and recovery may 
therefore be achieved with administration of glucocorticoids, 
as demonstrated in preliminary trials (Romundstad et al 2004, 
Kardash et al. 2008). 
Postoperative pain after bilateral hip arthroplasty (n = 12) with local infiltration of ropivacaine or saline intra-
operatively. Re-injection of ropivacaine or saline after 8 h (20 mL/40 mg) and 24 h (50 mL/100 mg). Values 
are median with twenty-fifth and seventy-fifth percentiles. VAS: visual analog scale, where 0 cm = no pain 
and 10 cm = worst pain. * p < 0.05. The arrows indicate re-injection times.
and paracetamol—with no addi-
tional pain relief using the high-
volume local infiltration anal-
gesia technique. These findings 
correspond to those in prospec-
tive, large-scale observational 
series after THA discharge 
(Andersen et al. 2009). Among 
the techniques mentioned, a 
multimodal non-opioid analge-
sic regimen may be preferable 
compared to epidural analgesia 
or peripheral femoral or poste-
rior lumbar plexus block, since 
these techniques may be asso-
ciated with motor side effects 
with potentially delayed post-
operative mobilization.
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Since the results reported in this study could possibly be 
the result of a type-2 error (i.e. a false negative result) due 
to the small number of observations, larger-scale trials may 
be needed to confirm our results. However, the inclusion of 
patients undergoing bilateral THA increases the strength of 
our data, and a study of similar design found a substantial 
analgesic effect of LIA in bilateral knee arthroplasty (Ander-
sen et al. 2008). Finally, the low pain scores achieved with the 
multimodal oral analgesia make it unlikely that a clinically 
important analgesic effect was overlooked.
In conclusion, the results from this randomized, double-
blind placebo-controlled trial in bilateral THA showed that 
there was no clinically relevant analgesic effect of intraop-
erative high-volume infiltration analgesia with 0.2% ropiva-
caine combined with repeated postoperative wound injections. 
Acceptable postoperative pain relief may be achieved with a 
multimodal oral analgesic regimen with gabapentin, cele-
coxib, and paracetamol.
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